Laurus Labs

{
  "main_header": {
    "sid": 1002699,
    "name": "Laurus Labs",
    "stock_name": "Laurus Labs",
    "full_name": "Laurus Labs Ltd",
    "name_url": "stocks-analysis/laurus-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,022.60",
    "chg": 30.05,
    "chgp": "3.03%",
    "dir": 1,
    "prev_price": "992.55",
    "mcapval": "55,205.73 Cr",
    "mcap": "Mid Cap",
    "scripcode": 540222,
    "symbol": "LAURUSLABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE947Q01028",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "7.72 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/laurus-labs-1002699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "RP",
      "url": "https://www.marketsmojo.com/mojopro/strategy/3",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/laurus-labs-1002699-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Laurus Labs Ltd Sees Significant Open Interest Surge Amidst Bullish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-ltd-sees-significant-open-interest-surge-amidst-bullish-market-signals-3910807",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LaurusLabsLtd_oi_spurts_by_underlying_3910807.png",
        "date": "2026-03-24 15:00:47",
        "description": "Laurus Labs Ltd (LAURUSLABS), a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant 11.74% surge in open interest (OI) in its derivatives segment on 24 Mar 2026, signalling heightened market participation and potential directional bets. The stock outperformed its sector peers with a 3.33% gain, reflecting growing investor confidence amid evolving market dynamics."
      },
      {
        "title": "Laurus Labs Ltd Sees Significant Open Interest Surge Amidst Bullish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-ltd-sees-significant-open-interest-surge-amidst-bullish-market-signals-3910674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LaurusLabsLtd_oi_spurts_by_underlying_3910674.png",
        "date": "2026-03-24 14:00:43",
        "description": "Laurus Labs Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 10.09% surge in open interest (OI) in its derivatives segment on 24 Mar 2026, signalling heightened market activity and potential directional bets. This increase accompanies a strong intraday price performance, with the stock outperforming its sector and broader indices, reflecting growing investor confidence and evolving market positioning."
      },
      {
        "title": "Laurus Labs Ltd Sees Significant Open Interest Surge Amidst Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-ltd-sees-significant-open-interest-surge-amidst-bullish-market-positioning-3910540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LaurusLabsLtd_oi_spurts_by_underlying_3910540.png",
        "date": "2026-03-24 13:00:31",
        "description": "Laurus Labs Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 10.27% surge in open interest (OI) in its derivatives segment on 24 Mar 2026, signalling increased market participation and potential directional bets. This rise accompanies a 3.35% gain in the stock price, outperforming its sector and broader indices, reflecting growing investor confidence amid mixed volume and liquidity patterns."
      },
      {
        "title": "Laurus Labs Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/laurus-labs-ltd-is-rated-buy-by-marketsmojo-3896214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LaurusLabsLtd_mojoScore_3896214.png",
        "date": "2026-03-17 10:10:45",
        "description": "Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Laurus Labs Ltd Valuation Shifts: Price Attractiveness Under the Microscope",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-ltd-valuation-shifts-price-attractiveness-under-the-microscope-3895611",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LaurusLabsLtd_valuationdot_3895611.png",
        "date": "2026-03-17 08:01:21",
        "description": "Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, prompting investors to reassess the stock's price attractiveness relative to its historical and peer benchmarks."
      },
      {
        "title": "Laurus Labs Ltd Hits Intraday Low Amid Price Pressure on 13 Mar 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-ltd-hits-intraday-low-amid-price-pressure-on-13-mar-2026-3888849",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LaurusLabsLtd_priceRelatedfactors_3888849.png",
        "date": "2026-03-13 10:31:04",
        "description": "Laurus Labs Ltd experienced a notable intraday decline on 13 Mar 2026, touching a low of Rs 991.9, down 5.16% from its previous close. The stock underperformed its sector and broader market indices amid persistent selling pressure and a generally bearish market environment."
      },
      {
        "title": "Laurus Labs Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/laurus-labs-ltd-is-rated-buy-by-marketsmojo-3875548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/LaurusLabsLtd_mojoScore_3875548.png",
        "date": "2026-03-06 10:11:01",
        "description": "Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Laurus Labs Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/laurus-labs-ltd-is-rated-buy-by-marketsmojo-3850449",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LaurusLabsLtd_mojoScore_3850449.png",
        "date": "2026-02-23 10:11:12",
        "description": "Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Laurus Labs Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/laurus-labs-ltd-is-rated-buy-by-marketsmojo-3850444",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LaurusLabsLtd_mojoScore_3850444.png",
        "date": "2026-02-22 10:10:41",
        "description": "Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 June 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of its performance and prospects."
      }
    ],
    "total": 668,
    "sid": "1002699",
    "stock_news_url": "https://www.marketsmojo.com/news/laurus-labs-1002699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
      "datetime": "12-Mar-2026",
      "details": "Please see annexed enclosure",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "11-Mar-2026",
      "details": "Please see annexed enclosure",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Mar-2026",
      "details": "Please see enclosed annexure",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Laurus Labs Ltd has declared <strong>40%</strong> dividend, ex-date: 31 Oct 25",
          "dt": "2025-10-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Laurus Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 29 Sep 20",
          "dt": "2020-09-29",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Laurus Labs Ltd Sees Significant Open Interest Surge Amidst Bullish Market Signals

2026-03-24 15:00:47

Laurus Labs Ltd (LAURUSLABS), a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a significant 11.74% surge in open interest (OI) in its derivatives segment on 24 Mar 2026, signalling heightened market participation and potential directional bets. The stock outperformed its sector peers with a 3.33% gain, reflecting growing investor confidence amid evolving market dynamics.

Read full news article

Laurus Labs Ltd Sees Significant Open Interest Surge Amidst Bullish Market Signals

2026-03-24 14:00:43

Laurus Labs Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 10.09% surge in open interest (OI) in its derivatives segment on 24 Mar 2026, signalling heightened market activity and potential directional bets. This increase accompanies a strong intraday price performance, with the stock outperforming its sector and broader indices, reflecting growing investor confidence and evolving market positioning.

Read full news article

Laurus Labs Ltd Sees Significant Open Interest Surge Amidst Bullish Market Positioning

2026-03-24 13:00:31

Laurus Labs Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 10.27% surge in open interest (OI) in its derivatives segment on 24 Mar 2026, signalling increased market participation and potential directional bets. This rise accompanies a 3.35% gain in the stock price, outperforming its sector and broader indices, reflecting growing investor confidence amid mixed volume and liquidity patterns.

Read full news article

Laurus Labs Ltd is Rated Buy by MarketsMOJO

2026-03-17 10:10:45

Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Laurus Labs Ltd Valuation Shifts: Price Attractiveness Under the Microscope

2026-03-17 08:01:21

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, prompting investors to reassess the stock's price attractiveness relative to its historical and peer benchmarks.

Read full news article

Laurus Labs Ltd Hits Intraday Low Amid Price Pressure on 13 Mar 2026

2026-03-13 10:31:04

Laurus Labs Ltd experienced a notable intraday decline on 13 Mar 2026, touching a low of Rs 991.9, down 5.16% from its previous close. The stock underperformed its sector and broader market indices amid persistent selling pressure and a generally bearish market environment.

Read full news article

Laurus Labs Ltd is Rated Buy by MarketsMOJO

2026-03-06 10:11:01

Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Laurus Labs Ltd is Rated Buy by MarketsMOJO

2026-02-23 10:11:12

Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Laurus Labs Ltd is Rated Buy by MarketsMOJO

2026-02-22 10:10:41

Laurus Labs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 June 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of its performance and prospects.

Read full news article

View All News